Victory Capital Management’s Nuvation Bio Inc Warrants NUVB.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-20,381
| Closed | -$6.73K | – | 2469 |
|
|
2025
Q4 | $6.73K | Hold |
20,381
| – | – | ﹤0.01% | 2414 |
|
|
2025
Q3 | $4.12K | Hold |
20,381
| – | – | ﹤0.01% | 2412 |
|
|
2025
Q2 | $5.5K | Sell |
20,381
-37,730
| -65% | -$8.72K | ﹤0.01% | 2474 |
|
|
2025
Q1 | $9.18K | Sell |
58,111
-440
| -0.8% | -$112 | ﹤0.01% | 2459 |
|
|
2024
Q4 | $13.5K | Sell |
58,551
-200
| -0.3% | -$26 | ﹤0.01% | 2463 |
|
|
2024
Q3 | $5.75K | Sell |
58,751
-350
| -0.6% | -$61 | ﹤0.01% | 2477 |
|
|
2024
Q2 | $9.46K | Sell |
59,101
-50
| -0.1% | -$10 | ﹤0.01% | 2469 |
|
|
2024
Q1 | $17.9K | Sell |
59,151
-1,940
| -3% | -$231 | ﹤0.01% | 2451 |
|
|
2023
Q4 | $3.67K | Hold |
61,091
| – | – | ﹤0.01% | 2536 |
|
|
2023
Q3 | $6.11K | Sell |
61,091
-640
| -1% | -$85 | ﹤0.01% | 2498 |
|
|
2023
Q2 | $10.2K | Hold |
61,731
| – | – | ﹤0.01% | 2483 |
|
|
2023
Q1 | $7.41K | Sell |
61,731
-2,320
| -4% | -$381 | ﹤0.01% | 2563 |
|
|
2022
Q4 | $9.26K | Hold |
64,051
| – | – | ﹤0.01% | 2547 |
|
|
2022
Q3 | $10K | Sell |
64,051
-1,650
| -3% | -$472 | ﹤0.01% | 2660 |
|
|
2022
Q2 | $18K | Hold |
65,701
| – | – | ﹤0.01% | 2625 |
|
|
2022
Q1 | $50K | Sell |
65,701
-1,940
| -3% | -$1.95K | ﹤0.01% | 2595 |
|
|
2021
Q4 | $128K | Sell |
67,641
-1,310
| -2% | -$2.97K | ﹤0.01% | 2542 |
|
|
2021
Q3 | $174K | Hold |
68,951
| – | – | ﹤0.01% | 2546 |
|
|
2021
Q2 | $179K | Hold |
68,951
| – | – | ﹤0.01% | 2547 |
|
|
2021
Q1 | $184K | Buy |
+68,951
| New | +$199K | ﹤0.01% | 2534 |
|
Victory Capital Management's NUVB.WS Position: Q1 2026 in Review
Victory Capital Management sold out of Nuvation Bio Inc Warrants (NUVB.WS) in Q1 2026, closing a stake of 20,381 shares — an estimated $6.73K sold.
Victory Capital Management first reported a position in NUVB.WS in Q1 2021 and held it in 20 quarters. The position peaked at $184K in Q1 2021. 0 funds tracked by Wall St. Rank hold NUVB.WS as of Q1 2026.
- Victory Capital Management reported no remaining Nuvation Bio Inc Warrants position as of Q1 2026 after selling out during the quarter.
- Victory Capital Management sold 20,381 Nuvation Bio Inc Warrants shares in Q1 2026, an estimated $6.73K.
- Victory Capital Management first reported a position in Nuvation Bio Inc Warrants in Q1 2021 and held it in 20 quarters.
- Victory Capital Management's Nuvation Bio Inc Warrants position peaked at $184K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Nuvation Bio Inc Warrants as of Q1 2026.
Based on Victory Capital Management's 13F filing for Q1 2026, filed 15 May 2026.